IAVI ReportImportant note: Information in this article was accurate in September 2001. The state of the art may have changed since the publication date.
Click here to return to IAVI Report main menu
Studies on Exposed Seronegative Cohorts

IAVI Report - July / September 2001


The Nairobi ESN women are not the only group of exposed seronegative individuals being followed prospectively. Similar examples of possible HIV resistance have been reported from other cohorts, which typically fall into one of three categories: commercial sex workers (CSW) (who are usually exposed to many different HIV strainst), "serodiscordant couples (wherein one partner is HIV-positive, the other, negative), and perinatally exposed infants (see article, "Closing in on Immune Protection in the Women of Pumwani").

Recently published or presented finding from CSW and serodiscordant couple cohorts are listed in the tables below and to the right.

Location  Investigators Type of cohort Source of Information
(journal or conference)
Data published or presented
Northern Thailand 
(Chiang Mai and Lamphun)
Chiang Mai HEPS Working Group Female sex workers J Infect Dis 1999 Jan;179(1):59-67
  • Criteria: >2yrs sex work, >2 STDs, HIV-1 seronegative
  • Resistance associated with HLA B18.
  • Env-specific IgA detected in the cervix of 6/13 ESN women.
Addis Ababa, Ethiopia Ethio-Netherlands AIDS Research Project Female sex workers AIDS Res Hum Retroviruses 2001 Mar 20;17(5):433-41
  • Criteria: >5yrs sex work, HIV-1 seronegative.
  • No evidence for role of certain non-immune factors in HIV resistance (co-receptor polymorphism, co-receptor expression levels, beta-chemokine production and cellular resistance to HIV infection in vitro).
Abidjan, Côte d'Ivoire Institute of Tropical Medicine, Belgium Female sex workers International Conference on AIDS 2000:Durban, SA, Abstract No. WePeA3995
  • Some evidence of decreased CXCR4 expression and increased beta-chemokine production in both ESN and HIV+ FSW.
Chiang Rai, Thailand Thai Ministry of Public Health and US CDC Female sex workers AIDS Res Hum Retroviruses 2001 May 20;17(8):719-34

International Conference on AIDS 1998: Geneva, Switzerland, Abstracts No. 599/31120 & 603/31127

6th Conference on Retroviruses and Opportunistic Infections 1999: Chicago, Abstract No. 83

  • Criteria: >3yrs sex work, HSV-2 & syphillis+, HIV-1 seronegative.
  • Resistance associated with HLA-A11
  • CTL responses to HLA-A-matched subtype E peptides (most commonly to Nef, also to Pol, Gag, Env) detected in 4/7 ESN.
  • ESNs tended to have higher frequencies of polymorphisms in both the CCR5 promoter region  and the gene for the chemokine SDF-1 (both aassociated with slower progression in HIV+ individuals) and higher spontaneous RANTES production by PBMC.
  • Novel CD4/CD14-associated HIV suppressive activity detected in the blood.
Location  Investigators Type of cohort Source of Information
(journal or conference)
Data published or presented
Chiang Mai, Thailand Thai Couples HEPS Group Serodiscordant couples 6th Conference on Retroviruses and Opportunistic Infections 1999: Chicago, Abstract No. 51
  • ESNs from a cohort of women married to HIV-infected men were compared to wives who became infected. Factors that did not differ between the two groups: HLA class I alleles, CCR5 D32 genotype and prsence of SLP1 (an HIV-inhibiting protein) in the cervicovaginal lavage.
  • Husbands' samples showed no differences in seminal viral load, HIV co-receptor use or defects in viral accessory genes.
  • More than half the ESNs showed HIV-specific T-cell responses.
  • ESNs showed CD14-associated HIV suppressive activity
London, UK Imperial College School of Medicine
(St. Mary's, London) and MRC Human Immunology Unit, John Radcliffe Hospital
(Oxford, UK)
Serodiscordant couples Conference on Retroviruses and Opportunistic Infections 2000: Chicago, Abstract Nos. 52 & 53
  • No mutations in CCR5 co-receptor gene or its promoter region.
  • HIV-specific CD8 T-cells detected in 8/8 ESN partners.
  • Responses to whole HIV proteins but not known peptides, suggesting that responses are directed at unmapped CTL epitopes.
  • Gag-specific CD4 T-cell responses detected in 3/5 ESN tested.
New Jersey, USA Gladstone Instittute/
Heterosexual AIDS Transmission Study (HATS)
Serodiscordant couples 8th Conference on Retroviruses and Opportunistic Infections 2001: San Francisco, Abstract No. 595
  • 13/16 ESN women showed ELISPOT responses to at least one antigen tested (gag, pol, nef, and env); 9/16 responded to multiple antigens.
  • 5/16 showed responses at multiple time points.
Lusaka, Zambia University of North Carlolina Serodiscordant couples International Conference on AIDS 2000:Durban, SA, Abstract No. WeOrA596
  • Responded to whole HIV proteins (Gag, Env, Pol).
  • HIV-specific CTL detected in 7/37 ESN.
Seattle, Washington USA University of Washington School of Medicine and Fred Hutchinson Cancer Research Center Serodiscordant couples J Infect Dis 1999 Mar;179(3):548-57
  • 13/36 ESN showed HIV-specific CTL
  • 4/26 had lymphoproliferative responses (top24, gp160 or gp120) detected in 4/36 ESN.
  • 1/36 homozygous for the CCR5 D32 mutation, 10/36 heterozygous.
  • HIV-specific CTL more commonly detected in individuals with wild-type CCR5 genotype.

010710
IAVI2001-0708


©2001. The IAVI Report.

AEGiS is made possible through unrestricted grants from Boehringer Ingelheim, iMetrikus, Inc., John M. Lloyd Foundation, the National Library of Medicine, and donations from users like you. Always watch for outdated information. This article first appeared in 2001. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1990, 2001. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.